Trust Company of the Ozarks’s Edwards Lifesciences EW Stock Holding History

Trust Company of the Ozarks’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$380K	Hold	16,020	–	–	0.13%	130
2015 Q2	$380K	Hold	16,020	–	–	0.11%	135
2015 Q1	$380K	Hold	16,020	–	–	0.1%	133
2014 Q4	$340K	Sell	16,020 -4,260	-21%	-$85.6K	0.09%	137
2014 Q3	$346K	Sell	20,280 -900	-4%	-$14.2K	0.1%	135
2014 Q2	$303K	Hold	21,180	–	–	0.08%	145
2014 Q1	$262K	Hold	21,180	–	–	0.07%	150
2013 Q4	$232K	Buy	+21,180	New	+$239K	0.07%	152

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Trust Company of the Ozarks's EW Position: Q3 2015 in Review

Trust Company of the Ozarks held its Edwards Lifesciences (EW) position steady in Q3 2015 at 16,020 shares worth $380K. The position accounts for 0.13% of the portfolio, ranked #130.

Trust Company of the Ozarks first reported a position in EW in Q4 2013 and has held it in 8 quarters since. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

Trust Company of the Ozarks held 16,020 shares of Edwards Lifesciences worth $380K as of Q3 2015.
Trust Company of the Ozarks left its Edwards Lifesciences share count unchanged in Q3 2015.
Edwards Lifesciences made up 0.13% of Trust Company of the Ozarks's portfolio in Q3 2015, its #130 holding.
Trust Company of the Ozarks first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 8 quarters since.
569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.